688366.SS
688366.SS
CNE100003NX4
SHANGHAI HAOHAI BIOLOGICAL TECH
Loading chart...

Company Profile

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequency, and ultrasonic instruments. It also engages in the research and development of biological engineering and pharmaceutical products and related technology transfer activities, consulting, and other services; research, development, production, and sales of radio frequency instruments; cell technology and biochemical product technology research and development; computer, communication, and other electronic equipment manufacturing; instrument manufacturing; manufacture and sale of biological reagents, biological agents, and biological materials; medical-grade sodium hyaluronate bio-based skincare products; intraocular lens and related products; intraocular lens injectors and materials, equipment, chemical products, and accessories for contact lenses and artificial lenses; sale of ophthalmology products; and provision of other machines and accessories. In addition, the company is involved in property management; business management consulting; non-residential real estate leasing; provision of technical services, technology promotion, development and transfer, technical consulting and exchange; wholesale of cosmetics; import and export of goods; import and export of technology; and information technology consulting services. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. The company was founded in 2007 and is headquartered in Shanghai, China.

Related stocks

9887.HK
9887.HK • China
LEADS BIOLABS-B
45.56 HKD
1.15B USD 1Y -37.5%
300841.SZ
300841.SZ • China
KANGHUA BIOLOGICAL
55.26 CNY
1.07B USD 1Y -28.5%
300294.SZ
300294.SZ • China
BOYA BIOLOGY
14.88 CNY
1.12B USD 1Y -40.6%
002030.SZ
002030.SZ • China
DAJY
6.03 CNY
1.27B USD 1Y -6.1%
000990.SZ
000990.SZ • China
CHENGZHI
6.41 CNY
1.17B USD 1Y +22.1%
1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
688177.SS
688177.SS • China
BIO THERA SOLUTIONS LTD
19.3 CNY
1.2B USD 1Y -31.6%
9966.HK
9966.HK • China
ALPHAMAB-B
7.36 HKD
905.95M USD 1Y -47.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.8% p.a.
Max Drawdown (5Y)
-76.5%
Sharpe Ratio (5Y)
-0.64
Beta Factor
0.45
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 46.6 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -76.5% in the extended horizon.
ende